Conéctate Aprende Finanzas
Retmarker SA

Retmarker SA

para calificar esta empresa
Portugal
8 empleados
Fundada en 2008

Descripción de la empresa


The company’s objective, to build a valuable global business on affordable healthcare for retinal diseases, relies on the Retmarker Technology and Operating Model. Retmarker, a patented and certified medical device, is a biomarker for Diabetic Retinopathy progression. Diabetic Retinopathy is the eye-sight complication of Diabetes (382 Million today and 592 Millions estimated in 2035) and the leading cause of blindness in the working population. To avoid blindness, all Diabetics should be screened at least once a year in order to provide early and timely treatment. Retmarker has been used with success in Diabetic Retinopathy Screening Programs since 2011. The aim of Retmarker is not to replace doctors and specialists, rather to provide efficient solutions that empower them to provide the best healthcare to those threatened by Diabetic Retinopathy. Retmarker allows the implementation of highly reliable and efficient Diabetic Retinopathy screening programs, at an extremely low cost.
Sector / Industria

{{industry.name}}
Productos y Servicios
{{pas.productName}}
Mostrar más

Información comercial


Principales clientes:

Public Health Systems

Certificaciones:

ISO 13485 (Medical Devices), ISO 9001, Patented Technology

Información de contacto


Para ver este contenido
Inicia sesión en ConnectAmericas
Ingresa el email con el que te registraste
en ConnectAmericas para crear
una nueva contraseña